Effects of Vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes results of the HOPE study and MICRO-HOPE substudy

Diabetes Care

Volumn 25, Issue 11, 2002, Pages 1919-1927

  Lonn, Eva ^a   Yusuf, Salim ^a   Hoogwerf, Byrcon ^b   Pogue, Janice ^a   Yi, Qilong ^a   Zinman, Bernard ^c   Bosch, Jackie ^a   Dagenais, Gilles ^d   Mann, Johannes F E ^e   Gerstein, Hertzel C ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; RAMIPRIL; GLYCOSYLATED HEMOGLOBIN; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFECT; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; RANDOMIZATION; REVASCULARIZATION; STROKE; UNSTABLE ANGINA PECTORIS; VITAMIN SUPPLEMENTATION; AGED; BLOOD; CEREBROVASCULAR ACCIDENT; CLASSIFICATION; COMPARATIVE STUDY; DIABETIC ANGIOPATHY; FEMALE; HEART DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEART DISEASES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MYOCARDIAL INFARCTION; PLACEBOS; SURVIVAL RATE; TREATMENT OUTCOME; VITAMIN E;

EID: 0036834582     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.11.1919     Document Type: Article

References (26)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL: Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989
2. Haffner SM: Clinical relevance of the oxidative stress concept. Metabolism 49 (Suppl. I):30-34, 2000
3. Meydani M. Vitamin E: Lancet 345:170-175
4. Andrew R, Skyrme-Jones P, O'Brien RC, Berry KL, Meredith IT: Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. J Am Coll Cardial 36:94-102, 2000
5. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328: 1444-1449, 1993
6. Rimm EB, Stampfer MJ, Ascherio A, Giovannuci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450-1456, 1993
7. Bursell S-E, King GL: Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications? Diabetes Res Clin Pract 45:169-182, 1999
8. The Alpha-Tocopherol, Beta-carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer in male smokers. N Engl J Med 330:1029-1035, 1994
9. Collaborative Group of the Primary Prevention Project (PPP): Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 357:89-95, 2001
10. GISSI-Prevenzione Investigators (Gruppo: Itallano per lo Studio della Sopravvivenza nell'Infarto miocardico): Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447-455, 1999
11. Rapola LM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP: Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 349: 1715-1720, 1997
12. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators: Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 342:154-160, 2000
13. Gerstein HC, Bosch J, Pogue J, Taylor DW, Zinman B, Yusuf S, for the HOPE Study Investigators: Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes: the MICRO-HOPE study. Diabetes Care 19:1225-1228, 1996
14. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355: 253-259, 2000
15. Lonn EM, Yusuf S, Dzavik V, Doris IC, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley W, Teo K, for the SECURE Investigators: Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103:919-925, 2001
16. Brown G, Zhao X-Q, Chait A, Fisher LD, Cheung ME, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583-1592, 2001
17. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ: Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781-786, 1996
18. Heart-Protection Study Collaborative Group: MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:23-33, 2002
19. Salonen JT, Nyyssõnen K, Tuomainen T-P, Mäenpää PH, Korpela H, Kaplan GA, Lynch J, Helmrich SP, Salonen R: Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ 311:1124-1127, 1995
20. Goguen JM, Leiter AL: Alternative therapy: the role of selected minerals, vitamins, fiber and herbs in treating hyperglycemia. Evidence-Based Diabetes Care, Gerstein HC, Haynes B, Eds. BC Decker, Hamilton, ON, Canada 2001, p. 295-322
21. Kunisaki M, Bursell S-E, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL: Vitamin E prevents diabetes-induced abnormal retinal flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 269:E239-E246, 1995
22. Craven PA, De Rubertis FR, Sagan VE, Melhem M, Studer RK: Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size. J Am Soc Nephrol 8:1-16, 1997
23. Bursell S-E, Clermont AC, Aiello LP, Aiello LM, Schlossman DK, Feener EP, Laffel L King GL: High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22: 1245-1251, 1999
24. Neslihan BT, Bayraktar M, Varli K: Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes. Diabetes Care 21:1915-1918, 1998
25. Steinberg D: Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? Lancet 346:36-38, 1995
26. Meagher EA, Barry OP, Lawson JA, Rokach J, Fitzgerald GA: Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285:1178-1182, 2001